World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: IRCT
Last refreshed on: 22 February 2018
Main ID:  IRCT201103025955N1
Date of registration: 2012-04-30
Prospective Registration: No
Primary sponsor: Vice Chncellor For Research Hamedan University Of Medical Siences
Public title: the effect of Mg sulfate and Nifedipine effect on umbilical cord blood PH
Scientific title: Comparison of Mg sulfate and Nifedipine effect on umbilical cord blood PH in neonates 23-36 age of gestation
Date of first enrolment: 2011-03-23
Target sample size: 60
Recruitment status: Complete
URL:  http://en.irct.ir/trial/6431
Study type:  interventional
Study design:  Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention.  
Phase:  N/A
Countries of recruitment
Iran (Islamic Republic of)
Contacts
Name: Dr .Shohreh Alimohamadi   
Address:  Fatemieh Hospital ; Kermanshah Street ; Hamedan 65177-89971 Hamedan Iran (Islamic Republic of)
Telephone: +98 81 1827 0713
Email: Dr-alimohamadi@yahoo.com
Affiliation:  Hamedan University Of Medical Siences
Name: Faezeh Moshayedi   
Address:  Fatemieh Hospital; Kermanshah Street ; Hamedan 65177-89971 Hamedan Iran (Islamic Republic of)
Telephone: +98 81 1827 7012
Email: Dr_alimohamadi@yahoo.com ; f.moshayedi@umsha.ac.ir
Affiliation:  Hamedan University Of Medical Sciences
Key inclusion & exclusion criteria
Inclusion criteria: Inclusion Criteria: Pregnant women 23-36 week of gestation; intact amniotic membrane; No fetal abnormality in ultrasound; Single; Stable maternal vital sign.
Exclusion Criteria: Rubture of membrane; multi gestation

Exclusion criteria:

Age minimum: no limit
Age maximum: no limit
Gender: Female
Health Condition(s) or Problem(s) studied
Cord PH in preterm neonates.
Labour and delivery complicated by biochemical evidence of fetal stress
Labour and delivery complicated by biochemical evidence of fetal stress
Intervention(s)
In the first group, that accidentally were treated with Mg-sulfate, 30 minutes after hydration and analgesic agents , Mg sulfate was started in this protocol : 4 gr IV slow infusion in 10 minutes, after that 2 gr in 100 cc ringer lactete serum was continued until the uterine contractions were cut.
Intervention 1: In the second group, 30 minutes after hydration and analgesic agents , Nifedipine was initiated in this protocol : At first ,10 mg , and every 8 hours until 24 hours ; and then 20 mg every 8 hours , until the second 24 hours . And treatment was cut. Intervention 2: In the first group, that accidentally were treated with Mg-sulfate, 30 minutes after hydration and analgesic agents , Mg sulfate was started in this protocol : 4 gr IV slow infusion in 10 minutes, after that 2 gr in 100 cc ringer lactete serum was continued until the uterine contractions were cut.
In the second group, 30 minutes after hydration and analgesic agents , Nifedipine was initiated in this protocol : At first ,10 mg , and every 8 hours until 24 hours ; and then 20 mg every 8 hours , until the second 24 hours . And treatment was cut.
Prevention
Primary Outcome(s)
Umbilical Cord blood Ph In preterm Neonates. Timepoint: After Delivery. Method of measurement: Ph measure with Technomedia Blood Gass Device.
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Vice Chncellor For Research Hamedan University Of Medical Siences
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
Ethics and research committee of Hamedan University Of Medical Sciences
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history